BIOA

BioAge Labs (BIOA)

About BioAge Labs (BIOA)

BioAge Labs, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapeutic products for metabolic diseases, such as obesity, by targeting the biology of human beings. It offers Azelaprag, a potential oral therapeutic for obesity, followed by several earlier-stage metabolic programs. The company was founded by Kristen Fortney and Eric Morgen on April 1, 2015 and is headquartered in Emeryville, CA.

Details

Daily high

$18.09

Daily low

$16.07

Price at open

$16.47

52 Week High

$24.00

52 Week Low

$4.06

Market cap

801.9M

Dividend yield

0.00%

Volume

436,925

Avg. volume

410,897

P/E ratio

-7.50

BioAge Labs News